Construction of Rare Disease Data Registry of Japan for autoimmune disease, and long-term nationwide multi-institutional researches utilizing the registry

RAre Disease DAta Registry of Japan[60] - RADDAR-J [60]

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000043071

Enrollment

5000

Registered

2021-02-15

Start date

2021-02-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic lupus erythematosus Antiphospholipid syndrome Polymyositis / Dermatomyositis Mixed connective tissue disease Sjogren&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients diagnosed with the autoimmune diseases according to the diagnostic criteria of the Ministry of Health, Labor and Welfare. Patients who consented to participate in the study in writing.

Exclusion criteria

Exclusion criteria: Patients judged to be inappropriate as a target by the judgment of researchers.

Design outcomes

Primary

Measure	Time frame
death and relapse during 10 years	—

Secondary

Measure	Time frame
Lung, renal, cardiovascular, pulmonary artery, neurological, and skin lesions due to underlying autoimmune diseases. Macrophage activation syndrome. Adverse events(malignancy, infection requiring hospitalization, cardio-cerebrovascular diseases, bone fracture, drug eruption). Severity and disease activity of underlying autoimmune diseases. Patient-reported outcome. EQ-5D-5L.	—

Countries

Japan

Contacts

Public Contacttakahiko sugihara

St. Marianna University School of Medicine Division of Rheumatology and Allergy, Department of Internal Medicine

takahikosugihara03240925@gmail.com044-977-8111

Outcome results